Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_828AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1NoViral strain in combination with DNR 240 ng/mlNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay40 MOI42% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_829AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1NoViral strain in combination with DNR 300 μg/kgNoNANANANANANANANAXenograft BALB/c nu/nu female mice subcutaneously injected with 1.0E+7 × 10⁷ K562 cells in a total volume of 100 μl1.0E+9 pfu/mlNA Reduction in tumor volume to 20 cubic millimeter compared to control 880 cubic millimeter after 30 daysIntratumoralEnhanced apoptosis activation is observedNANA27472927
OV_830AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoNANANANANANANANAXenograft BALB/c nu/nu female mice subcutaneously injected with 1.0E+7 × 10⁷ K562 cells in a total volume of 100 μl1.0E+9 pfu/mlNA Reduction in tumor volume to 80 cubic millimeter compared to control 880 cubic millimeter after 30 daysIntratumoralEnhanced apoptosis activation is observedNANA27472927
OV_831AdenovirusSG611DNAAdenoviridaeNoneYesNoNoNANANANANANANANAXenograft BALB/c nu/nu female mice subcutaneously injected with 1.0E+7 × 10⁷ K562 cells in a total volume of 100 μl1.0E+9 pfu/mlNA Reduction in tumor volume to 120 cubic millimeter compared to control 880 cubic millimeter after 30 daysIntratumoralEnhanced apoptosis activation is observedNANA27472927
OV_855AdenovirusCV890DNAAdenoviridaeE1A and E1B gene under control of Adenovirus promoterYesNoNoATCCNANANANANANANABALBc nude mice with Hep3B cell xenograft1.0E+11 pfuNA Complete reduction in tumor nodesintraperitonialNANANA11522637
OV_856AdenovirusCV890DNAAdenoviridaeE1A and E1B gene under control of Adenovirus promoterNoVirus strain in combination with Doxorubicin (10ng/ml)NoATCCHuman hepatoma cell lineHep3BNANAMTT assay0.01pfu/cell90% cancer cell killing after day 9, showing synergism with drugNoNoNA No responseNANANANA11522637
OV_857AdenovirusCV890DNAAdenoviridaeE1A and E1B gene under control of Adenovirus promoterYesNoNoATCCHuman hepatoma cell lineHep3BNANAMTT assay0.01pfu/cell35% cancer cell killing after day 9NoNoNA No responseNANANANA11522637
OV_922AdenovirusCNHK-300DNAAdenoviridaeAddition of 3 hTERT promoter in E boxes of genomeYesNoNoSynthesizedNANANANANANANABALB/c nude mice1.0E+9 pfuNA Tumor volume decreases to 600 mm3 after 20 days as compared to controlTail vein injection of virusNANANA15243805
OV_923AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoOnyx pharmaceuticalNANANANANANANABALB/c nude mice1.0E+9 pfuNA Tumor volume decreases to 200 mm3 after 20 days as compared to controlTail vein injection of virusNANANA15243805
OV_924AdenovirusCNHK-300DNAAdenoviridaeAddition of 3 hTERT promoter in E boxes of genomeYesNoNoSynthesizedNANANANANANANABALB/c nude mice1.0E+9 pfuNA Tumor volume decreases to 200 mm3 after 20 days as compared to controlTail vein injection of virusNANANA15243805
OV_925AdenovirusCNHK-300DNAAdenoviridaeAddition of 3 hTERT promoter in E boxes of genomeYesNoNoSynthesizedNANANANANANANABALB/c nude mice5.0E+8 pfu NA Tumor volume decreases to 500 mm3 after 20 days as compared to controlTail vein injection of virusNANANA15243805
OV_926AdenovirusCNHK-300DNAAdenoviridaeAddition of 3 hTERT promoter in E boxes of genomeYesNoNoSynthesizedNANANANANANANABALB/c nude mice1.0E+9 pfuNA Tumor volume decreases to 400 mm3 after 20 days as compared to controlTail vein injection of virusNANANA15243805
OV_927Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10 virus particle/cell70% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_928Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA100 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_929Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA1000 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_930Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10000 virus particle/ cellAll cancer cell survive after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_931Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_932Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA100 virus particle/ cell60% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_933Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA1000 virus particle/ cell60% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_934Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10000 virus particle/ cellAll cancer cell survive after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_935Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_936Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA100 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_937Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA1000 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_938Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10000 virus particle/ cell90% cancer cell survive after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_939Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA10 virus particle/cell90% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_940Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA100 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_941Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA1000 virus particle/ cell70% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_942Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA10000 virus particle/ cell70% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_943Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_944Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA100 virus particle/ cell70% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_945Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA1000 virus particle/ cell70% cancer cell survival after 6 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_946Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10000 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_947Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_948Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA100 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_949Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA1000 virus particle/ cell85% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_950Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA10000 virus particle/ cell90% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_951Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA10 virus particle/cell70% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_952Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA100 virus particle/ cell90% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_953Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA1000 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_954Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA10000 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_955Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA10 virus particle/cell70% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_956Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA100 virus particle/ cell75% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_957Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA1000 virus particle/ cell75% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_958Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA10000 virus particle/ cell80% cancer cell survival after 2 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_959Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10 virus particle/cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_960Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA100 virus particle/ cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_961Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA1000 virus particle/ cell60% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_962Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSK-N-SH4.0E+3 cells per wellNANA10000 virus particle/ cell20% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_963Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10 virus particle/cell100% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_964Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA100 virus particle/ cell100% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_965Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA1000 virus particle/ cell100% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_966Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSHSY5Y4.0E+3 cells per wellNANA10000 virus particle/ cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_967Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10 virus particle/cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_968Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA100 virus particle/ cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_969Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA1000 virus particle/ cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_970Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-794.0E+3 cells per wellNANA10000 virus particle/ cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_971Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA10 virus particle/cell70% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_972Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA100 virus particle/ cell70% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_973Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA1000 virus particle/ cell70% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_974Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineCHLA-204.0E+3 cells per wellNANA10000 virus particle/ cell70% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_975Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_976Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA100 virus particle/ cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_977Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA1000 virus particle/ cell50% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_978Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSKNBE4.0E+3 cells per wellNANA10000 virus particle/ cell20% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_979Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA10 virus particle/cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_980Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA100 virus particle/ cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_981Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA1000 virus particle/ cell85% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_982Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineSMS-SAN4.0E+3 cells per wellNANA10000 virus particle/ cell90% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_983Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA10 virus particle/cell100% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_984Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA100 virus particle/ cell100% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_985Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA1000 virus particle/ cell100% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_986Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineIMR-324.0E+3 cells per wellNANA10000 virus particle/ cell70% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_987Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA10 virus particle/cell70% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_988Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA100 virus particle/ cell75% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_989Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA1000 virus particle/ cell75% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_990Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoAlabama-BirminghamNeuroblastoma cell lineLan-54.0E+3 cells per wellNANA10000 virus particle/ cell80% cancer cell survival after 4 daysNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15570577
OV_1094AdenovirusZD55-IL-24DNAAdenoviridaeAdenovirus expressing ZD55 gene and IL-24 geneYesNoExpressing IL-24 geneShanghai cell collectionHuman cervical carcinoma cell lineHT-292.0E+6 cells per wellNAMTT assay5 MOI60% cell killing after 80 hoursNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15661558
OV_1095AdenovirusAd-IL-24DNAAdenoviridaeAdenovirus expressing IL-24 geneYesNoExpressing IL-24 geneShanghai cell collectionHuman cervical carcinoma cell lineHT-292.0E+6 cells per wellNAMTT assay5 MOI20% cell killing after 80 hoursNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15661558
OV_1096AdenovirusZD55-EGFPDNAAdenoviridaeAdenovirus expressing EGFP geneYesNoNoShanghai cell collectionHuman cervical carcinoma cell lineHT-292.0E+6 cells per wellNAMTT assay5 MOI40% cell killing after 80 hoursNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15661558
OV_1097AdenovirusZD55-IL-24DNAAdenoviridaeAdenovirus expressing ZD55 gene and IL-24 geneYesNoExpressing IL-24 geneShanghai cell collectionHuman cervical carcinoma cell lineSW6202.0E+6 cells per wellNAMTT assay5 MOINo cell killing after 80 hoursNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15661558
OV_1098AdenovirusAd-IL-24DNAAdenoviridaeAdenovirus expressing IL-24 geneYesNoExpressing IL-24 geneShanghai cell collectionHuman cervical carcinoma cell lineSW6202.0E+6 cells per wellNAMTT assay5 MOINo cell killing after 80 hoursNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15661558
OV_1099AdenovirusZD55-EGFPDNAAdenoviridaeAdenovirus expressing EGFP geneYesNoNoShanghai cell collectionHuman cervical carcinoma cell lineSW6202.0E+6 cells per wellNAMTT assay5 MOINo cell killing after 80 hoursNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15661558
OV_1100AdenovirusZD55-IL-24DNAAdenoviridaeAdenovirus expressing ZD55 gene and IL-24 geneYesNoExpressing IL-24 geneShanghai cell collectionHuman lung fibroblast cell lineNHLF2.0E+6 cells per wellNAMTT assay5 MOINo cell killing after 80 hoursNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15661558
OV_1101AdenovirusAd-IL-24DNAAdenoviridaeAdenovirus expressing IL-24 geneYesNoExpressing IL-24 geneShanghai cell collectionHuman lung fibroblast cell lineNHLF2.0E+6 cells per wellNAMTT assay5 MOINo cell killing after 80 hoursNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15661558
OV_1102AdenovirusZD55-EGFPDNAAdenoviridaeAdenovirus expressing EGFP geneYesNoNoShanghai cell collectionHuman lung fibroblast cell lineNHLF2.0E+6 cells per wellNAMTT assay5 MOINo cell killing after 80 hoursNoNoNA No responseNAApoptosis induction and cspase 3 activationNANA15661558
OV_1103AdenovirusZD55-IL-24DNAAdenoviridaeAdenovirus expressing ZD55 gene and IL-24 geneYesNoExpressing IL-24 geneShanghai cell collectionNANANANANANANAAthymic BALB/c nude mice xenograft for SW620 cell line5.0E+8 cells per wellNA Decrease in tumor volume below 800mm³ as compared to controlIntratumoral injectionApoptosis induction and cspase 3 activationNANA15661558
OV_1104AdenovirusAd-IL-24DNAAdenoviridaeAdenovirus expressing IL-24 geneYesNoExpressing IL-24 geneShanghai cell collectionNANANANANANANAAthymic BALB/c nude mice xenograft for SW620 cell line5.0E+8 cells per wellNA Decrease in tumor volume below 600mm³ as compared to controlIntratumoral injectionApoptosis induction and cspase 3 activationNANA15661558
OV_1105AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoShanghai cell collectionNANANANANANANAAthymic BALB/c nude mice xenograft for SW620 cell line5.0E+8 cells per wellNA Complete reduction in tumor volumeIntratumoral injectionApoptosis induction and cspase 3 activationNANA15661558
OV_1170AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (0.001 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI85% cell survivalNoNoNA No responseNANANANA17557108
OV_1171AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (0.01 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI75% cell survivalNoNoNA No responseNANANANA17557108
OV_1172AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (0.1 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI65% cell survivalNoNoNA No responseNANANANA17557108
OV_1173AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (10 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI40% cell survivalNoNoNA No responseNANANANA17557108
OV_1174AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (100 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI100% cell deathNoNoNA No responseNANANANA17557108
OV_1175AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (1000 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay0.1 MOI100% cell deathNoNoNA No responseNANANANA17557108
OV_1176AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (0.001 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI65% cell survivalNoNoNA No responseNANANANA17557108
OV_1177AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (0.01 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI55% cell survivalNoNoNA No responseNANANANA17557108
OV_1178AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (0.1 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI30% cell survivalNoNoNA No responseNANANANA17557108
OV_1179AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (10 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI10% cell survivalNoNoNA No responseNANANANA17557108
OV_1180AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (100 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI100% cell deathNoNoNA No responseNANANANA17557108
OV_1181AdenovirusICOVIR-5DNAAdenoviridaeNoneNoICOVIR-5 in combination with RAD001 drug (1000 micromolar)NoATCCHuman glioblastoma cell lineU-87 MG5.0E+3 cells per wellNAMTT assay1 MOI100% cell deathNoNoNA No responseNANANANA17557108